Accipiter Biosciences vs Recursion
Which Healthcare AI tool is better in 2026?
Accipiter Biosciences
AI-designed de novo protein therapies for complex diseases
Recursion
Pioneering AI-driven solutions in drug discovery to radically improve lives.
Side-by-side
Recursion is the more established option (raised $500M); pricing is comparable on both sides.
| Metric | Accipiter Biosciences | Recursion |
|---|---|---|
| Taglinei | AI-designed de novo protein therapies for complex diseases | Pioneering AI-driven solutions in drug discovery to radically improve lives. |
| Foundedi | 2025 | 2013🏆 |
| HQi | Seattle, United States | Salt Lake City, US |
| Employeesi | — | 501-1000🏆 |
| Neuron scorei | 68🏆 | 66 |
| Total fundingi | $12.7M | $500M🏆 |
| Latest roundi | Seed · Nov 2025 | IPO · Apr 2021 |
| Valuationi | — | $2B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Custom | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Accipiter Biosciences and Recursion.
| Capability | Accipiter Biosciences | Recursion |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Accipiter Biosciences
- Higher Neuron score (68 vs 66)
- Newer company (2025)
🔵 Strengths of Recursion
- Has raised more capital ($500M vs $12.7M)
- More mature (2013)
Which should you choose?
Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Recursion if you want the most established option — it has raised $500M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Accipiter Biosciences vs Recursion — which is better?
It depends on your priority. Accipiter Biosciences is the leaner option; Recursion has broader feature depth. See the side-by-side table above.
Is Accipiter Biosciences cheaper than Recursion?
No — Recursion's cheapest paid plan is Enterprise · Contact sales, while Accipiter Biosciences's is Custom.
Do Accipiter Biosciences and Recursion offer free plans?
Accipiter Biosciences: Paid only. Recursion: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.